- Home
- SCWO vs GRCE Comparison
SCWO vs GRCE Comparison
Compare SCWO & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCWO
- GRCE
- Stock Information
- Founded
- SCWO 2021
- GRCE 2002
- Country
- SCWO United States
- GRCE United States
- Employees
- SCWO N/A
- GRCE N/A
- Industry
- SCWO Environmental Services
- GRCE
- Sector
- SCWO Utilities
- GRCE
- Exchange
- SCWO Nasdaq
- GRCE NYSE
- Market Cap
- SCWO 39.9M
- GRCE 32.1M
- IPO Year
- SCWO N/A
- GRCE N/A
- Fundamental
- Price
- SCWO $0.32
- GRCE $2.80
- Analyst Decision
- SCWO
- GRCE Strong Buy
- Analyst Count
- SCWO 0
- GRCE 1
- Target Price
- SCWO N/A
- GRCE $12.00
- AVG Volume (30 Days)
- SCWO 170.6K
- GRCE 26.7K
- Earning Date
- SCWO 05-15-2025
- GRCE 05-19-2025
- Dividend Yield
- SCWO N/A
- GRCE N/A
- EPS Growth
- SCWO N/A
- GRCE N/A
- EPS
- SCWO N/A
- GRCE N/A
- Revenue
- SCWO $445,445.00
- GRCE N/A
- Revenue This Year
- SCWO $5,945.19
- GRCE N/A
- Revenue Next Year
- SCWO $106.82
- GRCE N/A
- P/E Ratio
- SCWO N/A
- GRCE N/A
- Revenue Growth
- SCWO N/A
- GRCE N/A
- 52 Week Low
- SCWO $0.25
- GRCE $1.75
- 52 Week High
- SCWO $1.99
- GRCE $4.97
- Technical
- Relative Strength Index (RSI)
- SCWO 54.08
- GRCE N/A
- Support Level
- SCWO $0.26
- GRCE N/A
- Resistance Level
- SCWO $0.29
- GRCE N/A
- Average True Range (ATR)
- SCWO 0.03
- GRCE 0.00
- MACD
- SCWO 0.01
- GRCE 0.00
- Stochastic Oscillator
- SCWO 70.00
- GRCE 0.00
About SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.